LUP-18548-89801
2 vaccinations
3 coded responses
4 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 402 / KY
- Registered
- 2021-01-31
- Relationship
- Self
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Feeling hot, Injection site nodule — Feeling: Good · Site: Pain, Redness, SwellingFree text: The injection site is hardened nodule about the size of silver dollar, and hot to the touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising, Injection site discolouration, Injection site induration — Feeling: Good · Site: Pain, Redness, SwellingFree text: Hard nodule and bruising, dark discoloration at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising, Injection site erythema, Nodule — Feeling: Good · Site: SwellingFree text: Pink with Bruising at injection site. Hard nodule decreased in size.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): The injection site is hardened nodule about the size of silver dollar, and hot to the touch
Systemic reaction (other): Hard nodule and bruising, dark discoloration at injection site.
Systemic reaction (other): Pink with Bruising at injection site. Hard nodule decreased in size.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site nodule | ✓ | ✓ | ✓ |
| SRO | Nodule | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release